[SCHEDULE 13G] MAIA Biotechnology, Inc. Passive Investment Disclosure (>5%)
MAIA: Solas Capital reports 7.1% stake
MAIA Biotechnology, Inc. Schedule 13G discloses that Solas Capital Management, LLC and Frederick Tucker Golden report shared beneficial ownership of 4,297,004 shares of common stock.
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
MAIA Biotechnology, Inc. Schedule 13G discloses that Solas Capital Management, LLC and Frederick Tucker Golden report shared beneficial ownership of 4,297,004 shares of common stock. The filing states this represents 7.1% of the class based on 60,671,491 shares outstanding as of March 23, 2026.
The filing states Solas acts as investment manager to a private fund and sub-adviser to another fund and that each fund disclaims beneficial ownership under Rule 13d-4; voting and dispositive power are reported as shared for the listed 4,297,004 shares.
Insights
Solas/Golden report a 7.1% shared stake in MAIA.
The filing documents Solas Capital Management, LLC and Portfolio Manager Frederick Tucker Golden as having shared voting and dispositive power over 4,297,004 shares, equal to 7.1% of the issuer's 60,671,491 outstanding shares as of March 23, 2026.
Because the Form is a Schedule 13G, it is a passive/beneficial-ownership disclosure under Rule 13d-4; subsequent filings would show any change in status or percent ownership.
Filing clarifies voting/dispositive powers and disclaimer treatment.
The statement shows shared voting and shared dispositive power for the 4,297,004 shares and includes a Rule 13d-4 disclaimer by the private funds managed or sub-advised by Solas, limiting direct attribution to the funds themselves.
Watch for future amendments or a Schedule 13D if the holder’s intent or activity changes; timing and cash-flow treatment are not stated here.
Key Figures
Shares owned:4,297,004 sharesPercent of class:7.1%Shares outstanding:60,671,491 shares
3 metrics
Shares owned4,297,004 sharesshared beneficial ownership reported by Solas/Golden
Percent of class7.1%based on 60,671,491 shares outstanding as of March 23, 2026
Shares outstanding60,671,491 sharesshares outstanding as represented by issuer in Form 10-K as of March 23, 2026
Key Terms
Schedule 13G, beneficial ownership, Rule 13d-4, shared dispositive power
4 terms
Schedule 13Gregulatory
"Item 1. Name of issuer: MAIA Biotechnology, Inc.; form header"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
beneficial ownershipregulatory
"Item 4. Ownership (a) Amount beneficially owned: Solas Capital Management, LLC is an investment adviser"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Rule 13d-4regulatory
"Pursuant to Rule 13d-4 , as amended, each of the Fund and the Other Fund expressly disclaims beneficial ownership"
shared dispositive powerfinancial
"Shared Dispositive Power 4,297,004.00 reported for Solas Capital Management, LLC"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Solas Capital report in MAIA (MAIA)?
Solas Capital Management, LLC and Frederick Tucker Golden report shared beneficial ownership of 4,297,004 shares, representing 7.1% of MAIA's common stock based on 60,671,491 shares outstanding as of March 23, 2026. The funds disclaim direct beneficial ownership.
How is voting and disposition authority reported for the MAIA stake?
The filing reports 0 sole voting power and 4,297,004 shares of shared voting power. It also reports 0 sole dispositive power and 4,297,004 shares of shared dispositive power for the same holdings.
Does the Schedule 13G indicate Solas will sell or buy MAIA shares?
No transaction direction is stated. The Schedule 13G is a beneficial-ownership disclosure showing a passive stake; it does not specify purchases, sales, or cash-flow treatment for the reported 4,297,004 shares.
What does the Rule 13d-4 disclaimer in the filing mean for MAIA ownership reporting?
The filing states the private fund and the other fund managed or sub-advised by Solas expressly disclaim beneficial ownership under Rule 13d-4, indicating the funds disclaim direct attribution of the reported shares despite Solas/Golden's managerial powers.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
MAIA Biotechnology, Inc.
(Name of Issuer)
Common Stock, $0.0001 par value per share
(Title of Class of Securities)
552641102
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
552641102
1
Names of Reporting Persons
Solas Capital Management, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
4,297,004.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
4,297,004.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
4,297,004.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.1 %
12
Type of Reporting Person (See Instructions)
IA, HC, OO
SCHEDULE 13G
CUSIP Number(s):
552641102
1
Names of Reporting Persons
FREDERICK TUCKER GOLDEN
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
4,297,004.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
4,297,004.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
4,297,004.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.1 %
12
Type of Reporting Person (See Instructions)
HC, IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
MAIA Biotechnology, Inc.
(b)
Address of issuer's principal executive offices:
444 WEST LAKE STREET, SUITE 1700, CHICAGO, ILLINOIS, 60606.
Item 2.
(a)
Name of person filing:
Solas Capital Management, LLC
Frederick Tucker Golden
(b)
Address or principal business office or, if none, residence:
Solas Capital Management, LLC
1063 Post Road, 2nd Floor
Darien, CT 06820
Frederick Tucker Golden
c/o Solas Capital Management, LLC
1063 Post Road, 2nd Floor
Darien, CT 06820
(c)
Citizenship:
Solas Capital Management, LLC - Delaware
Frederick Tucker Golden - United States
(d)
Title of class of securities:
Common Stock, $0.0001 par value per share
(e)
CUSIP Number(s):
552641102
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
Solas Capital Management, LLC is an investment adviser that is registered under the Investment Advisers Act of 1940. Solas Capital Management, LLC, which serves as the investment manager to a private fund (the "Fund") and as sub-adviser to another private fund (the "Other Fund"), which hold securities for the benefit of their investors, and Mr. Frederick Tucker Golden, as Portfolio Manager of Solas Capital Management, LLC, with the power to exercise investment and voting discretion, may be deemed to be the beneficial owners of all shares of Common Stock held by the Fund and by the Other Fund. Pursuant to Rule 13d-4 under the Securities Exchange Act of 1934, as amended, each of the Fund and the Other Fund expressly disclaims beneficial ownership over any of the securities reported in this statement, and the filing of this statement shall not be construed as an admission that either the Fund or the Other Fund are the beneficial owner of any of the securities reported herein.
Solas Capital Management, LLC - 4,297,004
Frederick Tucker Golden - 4,297,004
(b)
Percent of class:
Ownership percentage is based on 60,671,491 shares of common stock outstanding as of March 23, 2026, as represented by the Issuer in the Form 10-K filed with the Securities and Exchange Commission on March 23, 2026.
Solas Capital Management, LLC - 7.1%
Frederick Tucker Golden - 7.1%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Solas Capital Management, LLC - 0
Frederick Tucker Golden - 0
(ii) Shared power to vote or to direct the vote:
Solas Capital Management, LLC - 4,297,004
Frederick Tucker Golden - 4,297,004
(iii) Sole power to dispose or to direct the disposition of:
Solas Capital Management, LLC - 0
Frederick Tucker Golden - 0
(iv) Shared power to dispose or to direct the disposition of:
Solas Capital Management, LLC - 4,297,004
Frederick Tucker Golden - 4,297,004
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
See Notes above.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
See Notes above.
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Solas Capital Management, LLC
Signature:
/s/ Frederick Tucker Golden
Name/Title:
General Partner, Solas Capital Holdings, LP, its Member
